Vincent Brichard - Strategic Board Coordinator @ OncoDNA

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	FoRx Therapeutics	EQT Life Sciences	—	Series A - FoRx Therapeutics	obfuscated obfuscation
obfuscated obfuscation	FoRx Therapeutics	EQT Life Sciences	Yes	Series A - FoRx Therapeutics	obfuscated obfuscation
obfuscated obfuscation	ATB Therapeutics	EQT Life Sciences	Yes	Series A - ATB Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Minervax	EQT Life Sciences	—	Venture Round - Minervax	obfuscated obfuscation
obfuscated obfuscation	ImCheck Therapeutics	EQT Life Sciences	—	Series C - ImCheck Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Egle Therapeutics	EQT Life Sciences	Yes	Series A - Egle Therapeutics	obfuscated obfuscation
obfuscated obfuscation	FoRx Therapeutics	EQT Life Sciences	—	Seed Round - FoRx Therapeutics	obfuscated obfuscation
obfuscated obfuscation	ImCheck Therapeutics	EQT Life Sciences	—	Series B - ImCheck Therapeutics	obfuscated obfuscation

Number of Current Board & Advisor Roles

holds

board and advisor roles including

Board Member

Strategic Board Coordinator

, and

Board Member

Hub Name	CB Rank (Hub)
Health Care Early Stage Companies With More Than 100 Employees	59,278
Precision Medicine Startups	75,075
Verve Ventures Portfolio Companies	84,813
Health Diagnostics Early Stage Companies With More Than 10 Employees	67,999
Vesalius Biocapital Partners Portfolio Companies	79,931
Health Diagnostics Early Stage Companies With Less Than $50M in Revenue	101,746
S.R.I.W. Portfolio Companies	87,209
Precision Medicine Companies	19,209
Health Diagnostics Early Stage Companies With Less Than $1B in Revenue	73,638
Health Diagnostics Companies with Early Stage Venture Funding	68,108

There is no recent news or activity for this profile.